Awarded

2 - L2_VACUNA ANTIGRIPAL DE ANTÍGENOS DE SUPERFICIE INACTIVADOS DE VIRUS DE GRIPE DESARROLLADOS EN CULTIVO CELULAR, DESTINADA A PERSONAS CON ANTECEDEN

Track this recordFree account — get alerted when a contract here runs out.
Contract value
€9,240
Bids received
1
Published
30 May 2025
Awarded
29 May 2025
Contract start
29 May 2025
Contract end
30 May 2026estimated

More awards from this buyer